GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...

GlaxoSmithKline Group, Endo Pharmaceuticals, and Dendreon Pharmaceuticals. The companies lost customers’ full names, postal ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Similarly, whilst GlaxoSmithKline’s ... a far less strict delineation between 'pharmaceutical' and 'chemical' industries than we have nowadays. These companies focused as much on cod liver ...

As one of the fastest-growing major economies in the world, India has recorded a GDP growth of 7.6%* in FY 2023-24, owing to a strong rebound in economic activity. Rising disposable income levels ...

Tribune Online reports that some multinational pharmaceutical companies including GlaxoSmithKline and Sanofi Nigeria Ltd, exited the country within the past year. Related PostsNGX delists GSK ...

Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline. But there was ...

DelveInsight’s, “Head and Neck Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and ...

17-May-24 31-May-24 31-May-24 32 Rs.32.0000 per share(320%)Final Dividend 17-May-23 30-Jun-23 30-Jun-23 32 Rs.32.0000 per share(320%)Final Dividend 16-May-22 08-Jul-22 07-Jul-22 30 Rs.30.0000 per ...